Cathay Biotech Inc Market Cap ($3.77 Billion)
Market Cap & Net Worth: Cathay Biotech Inc (688065)
Cathay Biotech Inc market cap. Cathay Biotech Inc (SHG:688065) has a market capitalization of $3.77 Billion (CN¥25.79 Billion) as of November 1, 2026. Listed on the SHG stock exchange, this China-based company holds position #4135 globally and #563 in its home market, demonstrating a -2.38% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cathay Biotech Inc's stock price CN¥35.75 by its total outstanding shares 721289794 (721.29 Million). Also see how efficiently does Cathay Biotech Inc generate cash for how efficiently the company converts equity into cash flow.
Cathay Biotech Inc Market Cap History (2020–2026)
Cathay Biotech Inc market cap history from 2020 to 2026. Data shows change from $6.28 Billion to $3.77 Billion (-16.51% CAGR). Check 688065 live share price for real-time trading data and today's change.
Cathay Biotech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cathay Biotech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Cathay Biotech Inc annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.60x
Cathay Biotech Inc's market cap is 1.60 times its annual revenue
Latest Price to Earnings (P/E) Ratio
9.29x
Cathay Biotech Inc's market cap is 9.29 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $6.28 Billion | $1.50 Billion | $457.67 Million | 4.19x | 13.72x |
| 2021 | $13.71 Billion | $2.36 Billion | $594.72 Million | 5.80x | 23.05x |
| 2022 | $6.42 Billion | $2.44 Billion | $553.27 Million | 2.63x | 11.60x |
| 2023 | $5.78 Billion | $2.11 Billion | $366.52 Million | 2.73x | 15.76x |
| 2024 | $4.10 Billion | $2.96 Billion | $488.96 Million | 1.38x | 8.38x |
| 2025 | $5.26 Billion | $3.30 Billion | $565.72 Million | 1.60x | 9.29x |
Competitor Companies of 688065 by Market Capitalization
Companies near Cathay Biotech Inc in the global market cap rankings as of November 1, 2026. Also see 688065 current and non-current assets for a full breakdown of the balance sheet.
Key companies related to Cathay Biotech Inc by market ranking:
- BASF SE (F:BASA): Ranked #587 globally with a market cap of $45.63 Billion USD ( €39.03 Billion EUR).
- BASF SE (XETRA:BAS): Ranked #602 globally with a market cap of $44.62 Billion USD ( €38.17 Billion EUR).
- Dow Inc (NYSE:DOW): Ranked #1057 globally with a market cap of $24.65 Billion USD.
- Ningxia Baofeng Energy Group Co Ltd (SHG:600989): Ranked #1084 globally with a market cap of $23.94 Billion USD ( CN¥163.61 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #587 | BASF SE | F:BASA | $45.63 Billion | €13.20 |
| #602 | BASF SE | XETRA:BAS | $44.62 Billion | €53.46 |
| #1057 | Dow Inc | NYSE:DOW | $24.65 Billion | $34.70 |
| #1084 | Ningxia Baofeng Energy Group Co Ltd | SHG:600989 | $23.94 Billion | CN¥22.31 |
Market Capitalization of Cathay Biotech Inc (2020–2026)
Market capitalization of Cathay Biotech Inc from 2020 to today. Between 2020 and today, Cathay Biotech Inc's market cap moved from $6.28 Billion to $ 3.77 Billion, with a yearly change of -16.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥3.77 Billion | -28.21% |
| 2025 | CN¥5.26 Billion | +28.35% |
| 2024 | CN¥4.10 Billion | -29.09% |
| 2023 | CN¥5.78 Billion | -10.04% |
| 2022 | CN¥6.42 Billion | -53.16% |
| 2021 | CN¥13.71 Billion | +118.34% |
| 2020 | CN¥6.28 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 1st, 2026 the market cap of Cathay Biotech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.77 Billion USD |
| MoneyControl | $3.77 Billion USD |
| MarketWatch | $3.77 Billion USD |
| marketcap.company | $3.77 Billion USD |
| Reuters | $3.77 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cathay Biotech Inc
Cathay Biotech Inc., together with its subsidiaries, engages in the research, development, production, and sale of bio-based materials in China and internationally. The company offers biological long-chain diacids, including sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine under the TERRYL and ECOPENT brands. It also provides digital solutions for … Read more